Omnicell (MEX:OMCL) 9-Day RSI: N/A (As of Jul. 07, 2026)


MEX:OMCL Omnicell Inc MEX:OMCL
66 GF Score
Price MXN761.16
GF Value MXN651.97
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Omnicell 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-07), Omnicell's 9-Day RSI is N/A.

The industry rank for Omnicell's 9-Day RSI or its related term are showing as below:

MEX:OMCL's 9-Day RSI is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 52.67
* Ranked among companies with meaningful 9-Day RSI only.

Omnicell  (MEX:OMCL) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Omnicell 9-Day RSI Related Terms


MEX:OMCL vs TDOC, SDGR, OMDA: 9-Day RSI Comparison

For the Health Information Services subindustry, Omnicell's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell 9-Day RSI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Omnicell's 9-Day RSI falls into.


MEX:OMCL
66GF Score
Omnicell Inc MEX:OMCL
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omnicell  (MEX:OMCL) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Omnicell (MEX:OMCL) Overvalued in 2026?

Based on GuruFocus' analysis, Omnicell stock appears to be overvalued. The current stock price of MXN761.16 is trading 16.7% above its estimated GF Value™ of MXN651.97. GuruFocus considers Omnicell to be Significantly Undervalued.

Key valuation signals for MEX:OMCL:

  • 9-Day RSI: N/A
  • GF Value™: MXN651.97 vs. price of MXN761.16 (16.7% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the MEX:OMCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omnicell Business Description

Other Exchanges OMCL:USAOC9:Germany
Address 4220 North Freeway, Fort Worth, TX, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
66GF Score

Get the complete analysis for MEX:OMCL

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN761.16
Price
MXN651.97
GF Value